VRDN Q1 2026 Earnings NarrowerthanExpected Loss as Viridian Advances Clinical Pipeline ALGS Q1 2026 Earnings NarrowerThanExpected Loss as Aligos Therapeutics Advances Pipeline MX Q1 2026 Earnings Strong EPS Beat Provides Some Relief as Revenue Picture Remains Opaque ETR Q1 2026 Earnings EPS Slightly Misses Estimates Amid Operational Challenges SherwinWilliams SHW Q1 2026 Earnings Solid EPS Beat Amidst Mixed Demand Signals Targa Resources Q1 2026 Earnings Missed EPS Estimates but Stock Gains Amid Resilient Operations